Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Immucor inc. (manufacturer of the device) notified dominion biologicals limited of the intent to initiate a market withdrawal of cell 4 included in the panocell-10 ficin-treated lot 38324-e. cell 4 (donord1377) on this panel is listed as s+s- on the master list. in response to a report of unexpected negative reactivity on untreated cell 4 we have reproduced the customer's reported results. cell 4 has demonstrated reactivity varying from negative to 3+ using different sources of anti-s. cell 4 is one of four s+ red blood cells on this panel: cells 2 7 and 9 are also s+. cell 4 is the only s+s- cell on this panel.